Success Metrics

Active Trials
1(20%)

Phase Distribution

Ph not_applicable
1
20%

Phase Distribution

0

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution1 total trials
N/ANon-phased studies
1(100.0%)

Highest Phase Reached

Unknown

Trial Status & Enrollment

Completion Rate

0.0%

0 of 0 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

1

trials recruiting

Total Trials

5

all time

Status Distribution
Active(1)
Other(4)

Detailed Status

unknown4
Recruiting1

Development Timeline

Analytics

Development Status

Total Trials
5
Active
1
Success Rate
N/A
Most Advanced
N/A

Trials by Phase

N/A1 (100.0%)

Trials by Status

recruiting120%
unknown480%

Recent Activity

1 active trials
Showing 5 of 5
recruiting

Long-term Follow-up of Children Born in the PETN Studies

NCT06534307
unknown

Prevalence of H.Pylori in CKD Patients

NCT05882968
unknown

Hepatorenal Dysfunctions Among Workers Exposed To Petroleum Products

NCT04815512
unknown

Renal Resistive Index as a Marker of Severity and Treatment Outcomes in Lupus Nephritis

NCT03958851
unknownnot_applicable

Serum Interleukin -21 Level in Patients With Severe Adverse Cutaneous Drug Reaction.

NCT03166241

Clinical Trials (5)

Showing 5 of 5 trials
NCT06534307

Long-term Follow-up of Children Born in the PETN Studies

Recruiting
NCT05882968

Prevalence of H.Pylori in CKD Patients

Unknown
NCT04815512

Hepatorenal Dysfunctions Among Workers Exposed To Petroleum Products

Unknown
NCT03958851

Renal Resistive Index as a Marker of Severity and Treatment Outcomes in Lupus Nephritis

Unknown
NCT03166241Not Applicable

Serum Interleukin -21 Level in Patients With Severe Adverse Cutaneous Drug Reaction.

Unknown

All 5 trials loaded

Drug Details

Intervention Type
DIAGNOSTIC TEST
Total Trials
5